#Auxly

[canadianjobbank]

Apply now: https://canadianjobbank.org/general-labourer-farm-111/

[hemp-pot]

HEMP.GG;Global Marijuana Updates: Italy Removes Ban On CBD Sales Tasmanian Hemp Crops Destroyed & More - Auxly C - Benzinga

Global Marijuana Updates: Italy Removes Ban On CBD Sales, Tasmanian Hemp Crops Destroyed & More - Auxly C  Benzinga source https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbWFya2V0cy9jYW5uYWJpcy8yMy8xMC8zNTE1NjgzMy9nbG9iYWwtbWFyaWp1YW5hLXVwZGF0ZXMtaXRhbHktcmVtb3Zlcy1iYW4tb24tY2JkLXNhbGVzLXRhc21hbmlhbi1oZW1wLWNyb3BzLWRlc3Ryb3llZC1tb3Jl0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzM1MTU2ODMz?oc=5

[vespirita]

Prefácio - Do Outro Lado do Espelho - Dr. Inácio Ferreira

Prefácio – Do Outro Lado do Espelho – Dr. Inácio Ferreira

Aos seguidores de plantão do Dr. Inácio, meu Salve. Hoje iniciaremos os comentários do livro “Do Outro Lado do Espelho”. Peço ao Bondoso Pai me auxlie nesse novo desafio. Muita paz.             Do Outro Lado do Espelho… Teria coragem suficiente para ver o seu verdadeiro reflexo no espelho da Vida? Como imaginaria você no seu reflexo? Belo por fora, mas podre por dentro? Ou vice-versa? Como…

[cannachiefsmedia-blog]

#1 Chuck Rifici, Chairman & CEO at Auxly

Corporate Bio

Chuck Rifici is a pioneer of the North American cannabis industry having created and managed opportunities that have positively impacted the Canadian landscape.  Chuck has founded and been involved in the creation of some of Canada’s largest and most successful cannabis efforts.  He is best known for having co-founded Canopy Growth Corporation (formerly Tweed Marijuana Inc.).

Today, Chuck is Chairman and CEO of Auxly Cannabis Group, a platform spanning the entire cannabis value-chain, minimizing risk while simultaneously maximizing exposure to multiple, geographically-diverse cannabis companies through a single source, and Founder and CEO of Nesta Holding Co., a private equity firm that creates wide ranging partnerships and brands within the cannabis industry. He is also the former Chairman of National Access Cannabis/Meta Cannabis Supply Co., a global leader in medical and recreational cannabis retail.

Chuck is a chartered professional accountant (CPA). He obtained his MBA from Queen’s University and holds a BASc in Computer Engineering from the University of Ottawa.

Social Media Links:     TWITTER      LINKED IN      INSTAGRAM

Exclusive Interview

How did you get involved with the Cannabis Industry?

My relationship with cannabis dates back a number of years and looking back I can pinpoint a pivotal moments that sealed the deal for me. I knew there would be a future for cannabis in the business world back in 2010, when California voters considered legalizing recreational cannabis, the ballot failed by 2%, but I realized I almost missed the boat and I vowed that I wouldn’t miss that opportunity again.  That’s what got me scanning for new regulatory changes in Canada, and ultimately, that gave me a head start on others. When the Harper government released the draft regulations (creating the MMPR, now ACMPR) on a Sunday, I spent the whole night reading and stopped everything I had going, so I could put all my focus into this.  I don’t think I slept a full night again for 6 months.  

What is your biggest accomplishment to date in the Cannabis Industry?

Yeah it's a tough one, I mean there's been lots of interesting things, certainly being a Founder of Canopy, it's hard to escape that and its been positive for me and obviously they've grown to be pretty big but I think the second time is always sweeter and creating Auxly and pulling  the team I pulled together there and as we ramp up for the next wave of products with infused products, vape pens, edibles I am really excited with what we put together and the team we built and so that is what I am most proud of right now.

What are your future goals?

In the next five years looking forward  to the normalization of cannabis in Canada and the acceleration of global expansion and I guess what I mean about that is looking forward globally to the trade of cannabis where we start seeing countries being able to export large quantities of cannabis and cannabis molecules for both medical and recreational use  and really see the industry grow as we see additional countries legalize. On the path towards that I am really looking forward to the next country to legalize federally whether that is Mexico or a European country or maybe the United States, if we get an early surprise. I think once we have 3, 4, 5 countries, you know very quickly we are going to have 10 to 20, and then 40 -50. I think it's inevitable and that's the most exciting part.

Do you think that inevitable globalization of  federal legalization will put more emphasis on the Cannabis Industry partner ecosystem?

Yeah I think as the industry grows and matures the nice part is you don't have to do everything, and as a company if you try to do everything, you're not going to be good at everything,  you really can specialize to some degree and so its nice now, we see it today with oil processing licences, we have people specializing in extraction, we have people who are pure play retailers, and as the industry keeps growing it allows  businesses and entrepreneurs possibly be specialized and really go after a very specific market or market opportunity. I think it's exciting as it makes the business more accessible because you don't have to be a massive public company to get involved in the business. You can choose the piece you want to work on and there will people you can sell to and people you can buy services from to enable that business, so  I think there will be more and more opportunity that is going to get created as the industry gets bigger.

Who/What inspires you?

It's funny I have never really been asked that before, or at least not for a long time. Let's see, for me, I am a big fan of people like Elon Musk and entrepreneurs taking huge risks. I find inspiration from people who tackle really big ideas and try to change the world. I think the Cannabis Industry is certainly not the most important thing  in the world but doing our small part, and I think as Cannabis is Legalized in Canada and the industry grows, it allows for the dismantling of the drug war and all the negatives that can from that and so I really like that positive effect of everything we work on in the business.

Do you use Cannabis products? If yes, what are your favorite Cannabis products/brands?

I do. I like vape pens I think  it's a great product. I think it will be the largest segment in the recreational space. Although I tend not to smoke too much flower, I am really excited for what we have coming with our Robinsons product in Auxly which we know tests very well against other products from their medical product and we are really excited to unveil that to the rest of Canadians when we hopefully get our sales license for that facility later this year.

[licensedproducers]

First Wave of Cannabis 2.0 Products Hits Ontario

“Very Limited Supply” Only Available in 27 Stores Province-wide – LPC

The first wave of cannabis 2.0 products hits Ontario today, though it may seem more like a ripple. The Ontario Cannabis Store (OCS), which manages distribution in the province, said that there is a “very limited supply”. A spokesperson said that supply to be gone soon. “We expect products to sell out within the first week,” said OCS chief of staff David Lobo. “But it will improve, week after week.” The OCS shipped vapes, tea, chocolates, and gummies to 27 retail stores. It delayed selling them online due to limited supply. That means legal edibles won’t be available to over half the province. There isn’t any mention in the article below about how many products are available right now. Lobo said that 59 different products will be for sale in Ontario soon. Another OCS spokesperson, Daffyd Roderick, said that only two licensed producers (LPs) had products ready on December 16, 2019. That was the first day cannabis edibles, extracts, and topicals were legally available for sale in Canada. Some provinces including Manitoba, BC, and Saskatchewan made the first wave of cannabis 2.0 products available that week. Retailers reported cannabis 2.0 products flying off the shelves the first week. Ontario, Alberta, and Quebec weren’t ready due to government-run distribution chains. (Quebec also banned certain cannabis edibles.) Lobo said the OCS will “speed up” delivery of edibles if and when LPs deliver more supply.

First Wave of Cannabis 2.0 Products Seen as the New Frontier – LPC

So far, Canopy Growth supplied two kinds of Tokyo Smoke-branded milk chocolate. Canopy stated earlier that it planned from the start to launch its first wave of cannabis 2.0 products in January. It planned to stagger the launch of other products after that. Canopy has also taken a cannabis beverage gamble with its new bottling plant that can produce five million drinks per month. Meanwhile, Auxly Cannabis Group delivered 12 offerings to the OCS so far. Its line of first wave of cannabis 2.0 products includes four vapes, five soft-chew edibles, and three types of chocolate. All are through its wholly owned LP Dosecann Inc. Other LPs that have shipped to the OCS include Aurora Cannabis, Aphria, Redecan Pharm, Sundial Growers, Organigram, and Cronos Group. Analysts are hoping that the first wave of cannabis 2.0 products will help create another cannabis bull market in 2020. This editorial content from the LPC News Team provides analysis, insight, and perspective on current news articles. To read the source article this commentary is based upon, please click on the link below. Click here to view full story at business.financialpost.com Read the full article

[presssorg]

British Tobacco Imperial takes 20% stake in Cannabis Auxly investment of $123 million

Auxly Cannabis stock soars 20% as British tobacco giant Imperial takes 20% stake British tobacco company Imperial Brands is getting into the cannabis business with a $123 million investment in Auxly Cannabis, the Canadian company run by former Tweed founder Chuck Rifici. The British firm — which has no ties to Imperial Tobacco Canada — will take a 19.9 per cent ownership in Auxly through a debenture convertible, at a conversion price of $0.81 per share, which is a 11 per cent premium to Auxly’s closing share price as of July 24, 2019. Imperial will also get one out of five board seats at the Vancouver-based licensed producer, which will give it some oversight of corporate governance at the company. Auxly, for its part, will obtain the rights to Imperial’s vaping technology and vapor innovation business Nerudia, which the company says already has a team dedicated to cannabis research. “If you take a look at Imperial, the smoking part of their business is actually smaller than their peers, which allows them to be more aggressive with other kinds of products,” Rifici told the Financial Post. While Auxly’s core business is cannabis cultivation — it owns Robinsons, a craft cannabis brand based out of Nova Scotia, and Dosecann, a producer of CBD oil out in Prince Edward Island — the company intends to focus primarily on developing vape pens and other product forms besides dried flower that will be part of Canada’s second wave of legalization come October 2019. “The deal size is a great investment given the nature of current market conditions. This $123 million will really position us strongly on the balance sheet and removes the question of what Auxly is doing,” Rifici said.

“The deal size is a great investment given the nature of current market conditions. This $123 million will really position us strongly on the balance sheet and removes the question of what Auxly is doing,” Rifici said. He added that talks on an investment began as early as February, upon which Imperial conducted intensive due diligence before deciding to invest in Auxly. “We have never experienced a company go into so much detail on everything. It was a long process in a good way, and coming out from it we felt very validated,” said Rifici. Imperial is the second major tobacco company to make an investment in the Canadian cannabis space — in March, Altria finalized a $1.8 billion investment in licensed producer Cronos Group, which gave it a 45 per cent stake in the company, with the ability to increase that stake to 55 per cent through exercising warrants. Some investors in the space have expressed concern about the control large multinationals like Altria and Constellation Brands (with its investment in Canopy Growth Corp.) have over domestic cannabis companies — it was widely believed that the decision to terminate former Canopy CEO Bruce Linton came from Constellation. Rifici, however, sees Imperial’s stake in his company as a massive advantage. “They have capabilities all over the world that we don’t, and that just empowers, emboldens and supercharges everything for us, especially when it comes to government and investor relations.” The deal is expected to close in the third quarter of 2019 subject to approval by the TSX Venture Exchange, according to a company statement. BMO Capital Markets acted as Auxly’s financial advisor in connection with the deal. • Email: vsubramaniam@nationalpost.com | Twitter: VanmalaS Published at Thu, 25 Jul 2019 13:58:24 +0000 Read the full article

[nakedweed-blog1]

Auxly Cannabis Reports Q1 2019 Financial Results and Key Milestones .. https://bit.ly/2VyNtJz

[themorningblunt]

Tokers & Jokers | Weed Stocks Ring In The New Year Wednesday was 2019’s first trading session, with cannabis stocks generally trading up at the close of market.

[grimmtheautisticwerewolf]

New Canadian vaping items

On the off chance that you haven't been put off by the whirlwind of negative news headlines twirling around the potential dangers of vaping, this new category of cannabis consumables could be a welcomed approach to indulge. After all, vaping can be discreet and brands are attempting to create a number of items that make it easy and enjoyable to smoke.

However, not all Canadians will be able to purchase cannabis vape items. As per new decision in Alberta, cannabis vaping has been given the red light, and in Quebec, Newfoundland and Labrador

it additionally remains a no-go due to health concerns. Meanwhile, Health Canada keeps up that vaping can possibly be hurtful and that long haul effects remain obscure.

Kolab Project

Maker: Auxly

Dose: 255 mg of THC and 2.55 mg of CBD per 0.3g pen

Price: Approx. $59, prices differ by region

Vape pens from Kolab Project come in indica, sativa, just as mixture varieties and most will be high THC. Cartridges come in two sizes likewise: 0.3g, which has 255 mg of THC and 2.55 mg of CBD per unit; and 0.5g cartridges, with 425 mg of THC and 4.25 mg of CBD.

Marley Natural

Maker: High Park (Tilray)

Dose: Varies

Price: Approx. $49.99, prices fluctuate by region

In the event that you THC Vape Cartridge know anything about the weed world in the US, Marley Natural, a Bob Marley-branded cannabis line, may ring a bell. High Park has teamed up with the well-respected organization to carry it to Canada and is commencing the collab with its Marley Green vape cartridges. They contain pure CO2 winterized cross breed cannabis oil that is 75% to 85% THC, in addition to they work with most 510-thread vaporizer items.

Canaca

Maker: High Park (Tilray)

Dose: 400 mg or more of THC per pen

Price: Approx. $44.99, prices fluctuate by region

Canaca is one of the marque marks in the High Park portfolio and it prides itself on old fashioned Canadian heritage. The new vape pens will be added to the brand's already existing roster of dried flower, prerolls, and oil.

Namaste

Maker: Zenabis

Dose: 0.5 ml per unit

Price: Varies by region and retailer

Namaste's PAX Era Pods will dispatch in three strains including D Bubba (a sweet and earthy high-THC, low-CBD that is indica-prevailing), Ultra Sour (a heavy half and half that is sativa-predominant with citrus and diesel scents), and Citrique (a sativa-prevailing mixture that is high in THC with a lemonade-like flavor).

Juju

Maker: Canopy

Price: Starting from approx. $34.99, varies by region and retailer

For the tech-keen toker there are Juju Joints. These single-use vape pens are bluetooth-enabled and can be connected to a smartphone application that reveals information about the pen, like strain details and when to change the cartridge. They're recyclable and use a case based system.

Attack

Maker: Auxly

Price: Approx. $48.75, varies by region and retailer

Dose: 800 mg THC and 8 mg CBD per 0.3 ml pen

Expect natural product flavors from Foray's sativa-blend vape pen. The 0.3 ml disposable vape pen is rechargeable and uses leak-resistant tech to ensure no fluid gets inside of the device.

Dosist

Maker: Aphria

Price: Approx. $55, varies by region and retailer

Dose: 2.25 mg THC per hit

Dosist vape pens will come in a large and little size, depending on your preference. The former equals around 200 hits per pen while the latter is around 50. Both pack 2.25 mg of THC per hit. The come in different profiles, like Arouse (sativa-prevailing) and Blend (a half and half).

[canadianjobbank]

Apply now: https://canadianjobbank.org/general-labourer-farm-111/

[ihallandeinvesteringar]

Pressmeddelanden: CannTrust, OrganiGram, Auxly och Trulieve

#cannabisaktier #aktier #cbswe #swecan #sverige #nyheter #börsen Fyra pressmeddelanden från fyra olika bolag. Ett av bolagen har fått en licens, ett annat bolag har fått ett godkännande medan de andra två har annonserat när de släpper sina kvartalsrapporter. Det är spännande tider på marknaden framförallt med tanke på hur det går i USA.

Fyra pressmeddelanden från fyra olika bolag. Ett av bolagen har fått en licens, ett annat bolag har fått ett godkännande medan de andra två har annonserat när de släpper sina kvartalsrapporter. Det är spännande tider på marknaden framförallt med tanke på hur det går i USA.

OrganiGrams kommande kvartalsrapport

OrganiGram skall släppa sin kvartalsrapport för andra kvartalet i deet räkenskapsår som…

[vapebiz]

Imperial Brands To Invest £75 Million in Auxly Cannabis Group

Imperial Brands To Invest £75 Million in Auxly Cannabis Group

Imperial will invest 75 billion British pounds to acquire 19.9% stake in Auxly over a three-year term. This will enable Auxly to access Imperial’s licenses to its vaping technology and its brand, Nerudia.

The transaction between the two companies is estimated to close by the third quarter of 2019, building on Imperial’s first entry into the cannabis industry in June 2018, when it purchased a…

[cannabisresins]

At the heart of this excitement is Auxly Cannabis Group (NASDAQOTH: CBWTF), a cannabis streaming company and cultivation farm operator that just ... Read More...

[deepadelve]

Medical Marijuana- Competitive Intelligence Analysis, 2021

Medical marijuana is the use of the Cannabis sativa or Cannabis indica plant to treat or relieve symptoms. Until the early 1900s, the Cannabis plant was utilized medically all across the world for millennia. Cannabinoids are a group of compounds found in marijuana plants that number in the hundreds. Each has a distinct influence on the human body. The significant compounds utilized in medicine are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Marijuana plants are divided into two types: Indica and Sativa. Both of these species differ not only in quality but also in look and growth procedure. The Indian marijuana plant is distinguished by its stubby height, wide leaves, and dense leaves. Sativa, on the other hand, is known mainly for its tall body, broad leaves, and thin branches.

Forms of Medical marijuana

Natural Form: Marijuana comprises THC, Cannabidiol, and other cannabinoids and is derived from the Cannabis Sativa plant's leaves, stems, and flower buds. State regulations define “medical marijuana” as a herbal form made from dried components of the cannabis plant (available in only a few states), which is virtually the same form sold illegally.

Synthetic Form: Marinol (Dronabinol), a synthetic form of THC, is available on prescription, as is Cesamet, a newer synthetic form of THC (Nabilone). Synthetic THC has a different effect than “natural” cannabis. Because of the unknown components in natural cannabis, it cannot yet be manufactured. Synthetic cannabinoids have different chemical properties and are more water-soluble than THC, making them suitable for intravenous administration.

Semi-Synthetic Form: Sativex is a mixture of THC and cannabidiol that is exclusively available outside of the United States (Nabiximols). It comes in the form of a peppermint-flavored spray. It's a so-called "whole-plant" extract that contains THC and CBD in a 1:1 ratio. It comes straight from cannabis plants, however, it goes through a lengthy processing process.

Medical Marijuana Uses

The US Food and Drug Administration (FDA) has approved one cannabis-derived drug and three cannabis-related drugs: dronabinol (Marinol, Syndros), nabilone (Cesamet), and cannabidiol (CBD) (Epidiolex).

Chemotherapy-induced nausea and vomiting, as well as anorexia connected to weight loss in AIDS patients, can be treated with dronabinol and nabilone. Cannabidiol is a medication that can be used to treat children with severe epilepsy. According to the FDA we can use medical marijuana to treat cancer patients.

Medical marijuana Market Insight 

The Food and Drug Administration has yet to approve a cannabis marketing application for the treatment of any disease or condition. However, the FDA has approved Epidiolex (cannabidiol), a cannabis-derived medication, as well as three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). Only a prescription from a licensed healthcare provider is required to obtain these approved medication goods. 

Importantly, the FDA has not approved any other cannabis, cannabis-derived, or cannabidiol (CBD) medications already on the market, including GW Pharmaceuticals' EPIDIOLEX, Solvay Pharmaceuticals' MARINOL, and Valeant Pharmaceuticals' Cesamet.

Medical Marijuana Companies 

Some of the key players of the global Medical Marijuana Market include Canopy Growth Corporation, Aurora Cannabis, Auxly Cannabis Group, OrganiGram Holdings, GW pharmaceuticals, Cronos Group, Terra Tech Group, Aphria, Papa & Barkley, CannTrust Holdings, Mary’s Medicinals, Stenocare, and Tilray, among others.

About DelveInsight

DelveInsight is a renowned business consulting and market research firm specializing in the life sciences. It helps pharma companies improve their performance by delivering comprehensive end-to-end solutions. It also provides Healthcare Consulting Services, which include market analysis and practical solutions for accelerating corporate growth and overcoming problems.

[themorningblunt]

Tokers & Jokers | Cannabis Stocks Start the Week Strong

Tokers & Jokers | Cannabis Stocks Start the Week Strong #WeedStocks #PotStocks #CannabisNews #Finance #GreenRush #PennyStocks

US and Canadian cannabis stocks were largely on the rise Monday, with only a handful of stocks ending the day in the red.

Last week Ohio-based Green Growth Brands (OTCMKTS: GGBXF) (CSE: GGB) initiated a formal hostile takeover offer for Aphria Inc (NYSE: APHA). The deal however, is riddled with unorthodox terms, including an agreement to pay All JS Greenspace LLC — a company helping finance the…